Cargando…
Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China
To cope with the increasing healthcare costs brought about by the universal health insurance programme, national volume-based procurement (NVBP) was implemented in China to reduce drug prices. However, the impact of NVBP remains unknown. We reported the effects of the NVBP pilot programme on medicat...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438819/ https://www.ncbi.nlm.nih.gov/pubmed/34518200 http://dx.doi.org/10.1136/bmjgh-2021-005519 |
_version_ | 1783752418732802048 |
---|---|
author | Yuan, Jing Lu, Z Kevin Xiong, Xiaomo Jiang, Bin |
author_facet | Yuan, Jing Lu, Z Kevin Xiong, Xiaomo Jiang, Bin |
author_sort | Yuan, Jing |
collection | PubMed |
description | To cope with the increasing healthcare costs brought about by the universal health insurance programme, national volume-based procurement (NVBP) was implemented in China to reduce drug prices. However, the impact of NVBP remains unknown. We reported the effects of the NVBP pilot programme on medication affordability and discussed the challenges and recommendations for further reforms. A total of 25 molecules won the bidding in the NVBP pilot programme, and price cuts ranged from 25% to 96%. Medication affordability was measured as the number of days’ wages needed to pay for a course of treatment, and the medication was identified as affordable if the cost of a treatment course was less than the average daily wage. After the NVBP, the proportion of affordable drugs increased from 33% to 67%, and the mean affordability improved from 8.2 days’ wages to 2.8 days’ wages. Specifically, for rural residents, the proportion of affordable drugs increased from 13% to 58%, and the mean affordability improved from 15.7 days’ wages to 5.3 days’ wages. For urban residents, the proportion of affordable drugs increased from 54% to 71%, and the mean affordability improved from 5.9 days’ wages to 2.0 days’ wages. Implementing the NVBP substantially improved medication affordability. In future reforms, a multifaceted approach addressing all issues in the health system is needed to enhance medicine access. |
format | Online Article Text |
id | pubmed-8438819 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-84388192021-09-24 Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China Yuan, Jing Lu, Z Kevin Xiong, Xiaomo Jiang, Bin BMJ Glob Health Analysis To cope with the increasing healthcare costs brought about by the universal health insurance programme, national volume-based procurement (NVBP) was implemented in China to reduce drug prices. However, the impact of NVBP remains unknown. We reported the effects of the NVBP pilot programme on medication affordability and discussed the challenges and recommendations for further reforms. A total of 25 molecules won the bidding in the NVBP pilot programme, and price cuts ranged from 25% to 96%. Medication affordability was measured as the number of days’ wages needed to pay for a course of treatment, and the medication was identified as affordable if the cost of a treatment course was less than the average daily wage. After the NVBP, the proportion of affordable drugs increased from 33% to 67%, and the mean affordability improved from 8.2 days’ wages to 2.8 days’ wages. Specifically, for rural residents, the proportion of affordable drugs increased from 13% to 58%, and the mean affordability improved from 15.7 days’ wages to 5.3 days’ wages. For urban residents, the proportion of affordable drugs increased from 54% to 71%, and the mean affordability improved from 5.9 days’ wages to 2.0 days’ wages. Implementing the NVBP substantially improved medication affordability. In future reforms, a multifaceted approach addressing all issues in the health system is needed to enhance medicine access. BMJ Publishing Group 2021-09-13 /pmc/articles/PMC8438819/ /pubmed/34518200 http://dx.doi.org/10.1136/bmjgh-2021-005519 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Analysis Yuan, Jing Lu, Z Kevin Xiong, Xiaomo Jiang, Bin Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China |
title | Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China |
title_full | Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China |
title_fullStr | Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China |
title_full_unstemmed | Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China |
title_short | Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China |
title_sort | lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (nvbp) effect in china |
topic | Analysis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438819/ https://www.ncbi.nlm.nih.gov/pubmed/34518200 http://dx.doi.org/10.1136/bmjgh-2021-005519 |
work_keys_str_mv | AT yuanjing loweringdrugpricesandenhancingpharmaceuticalaffordabilityananalysisofthenationalvolumebasedprocurementnvbpeffectinchina AT luzkevin loweringdrugpricesandenhancingpharmaceuticalaffordabilityananalysisofthenationalvolumebasedprocurementnvbpeffectinchina AT xiongxiaomo loweringdrugpricesandenhancingpharmaceuticalaffordabilityananalysisofthenationalvolumebasedprocurementnvbpeffectinchina AT jiangbin loweringdrugpricesandenhancingpharmaceuticalaffordabilityananalysisofthenationalvolumebasedprocurementnvbpeffectinchina |